Seattle hospital testing brain trauma drug

Seattle hospital testing brain trauma drug


AP News

SEATTLE, Wash. – Patients who arrive unconscious with a head injury at Harborview Medical Center in Seattle may be given a drug being tested to prevent bleeding in the brain, even though they are unable to give their consent.

The hospital’s chief trauma doctor, Dr. Eileen Bulger, says the drug known as TXA is already approved to stop internal bleeding.

She’s leading the study to determine if giving the drug as early as possible helps with traumatic brain injury.

The hospital is currently doing community outreach.

Enrollment in the study won’t begin until it gets approval from a review panel at the University of Washington.

The Seattle Times reports that people can opt out by requesting a “NO-STUDY” bracelet (call 206-744-7724 or email

The study at Harborview and nine other trauma centers will involve about 1,000 patients, and about 100 of those are at Harborview.

Recent Headlines

in Entertainment

WATCH: 7 fun facts to make you think this Thanksgiving


Thanksgiving is a time of coming together with family and friends. In between bites of stuffing and pumpkin pie, snack on these unusual Turkey Day facts.

in Black Friday, Entertainment

Change your Amazon password now


With Black Friday and Cyber Monday quickly approaching, this might be the worst time of year for Amazon to have security concerns.

in Black Friday, Entertainment

PHOTOS: Macy’s Parade through the years


For 88 years the iconic Macy's Parade has been a Thanksgiving tradition.

in Local

Western’s black student body president says she no longer feels safe on campus


KGMI News BELLINGHAM, WASH. — The Western Washington University student body president says she received death threats and no longer…

in Entertainment

REVIEW: ‘Creed’ builds on the legacy of ‘Rocky’


"Creed" stays rooted in tradition while simultaneously taking the entire franchise in a new direction as vital as it is welcome.